Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B

被引：26
|
作者：
Amato, Valdir Sabbaga [1 ]
Tuon, Felipe Francisco [1 ]
Campos, Aleia [1 ]
Bacha, Helio Arthur [1 ]
Nicodemo, Antonio Carlos [1 ]
Neto, Vicente Amato [1 ]
Shikanai-Yasuda, Maria Aparecida [1 ]
机构：
[1] Univ Sao Paulo, Sch Med, Dept Infect & Parasit Dis, Sao Paulo, Brazil
来源：
CLINICAL INFECTIOUS DISEASES | 2007年 / 44卷 / 02期
关键词：
D O I：
10.1086/510494
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：311 / 312
页数：2
相关论文
共 50 条
  • [41] Topical Amphotericin B for the treatment of localized cutaneous leishmaniasis
    Alcantara-Reifs, Carmen Maria
    Garnacho-Saucedo, Gloria
    Salido-Vallejo, Rafael
    Velez Garcia-Nieto, Antonio
    DERMATOLOGIC THERAPY, 2017, 30 (01)
  • [42] Immunosuppressants and amphotericin B liposomalVisceral leishmaniasis and amphotericin B liposomal treatment failure: case report
    Reactions Weekly, 2017, 1645 (1) : 159 - 159
  • [43] Short Report: Can We Use a Lower Dose of Liposomal Amphotericin B for the Treatment of Mucosal American Leishmaniasis?
    Amato, Valdir S.
    Tuon, Felipe F.
    Camargo, Raphael A.
    Souza, Regina M.
    Santos, Carolina R.
    Nicodemo, Antonio C.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2011, 85 (05): : 818 - 819
  • [44] Highly Effective Oral Amphotericin B Formulation against Murine Visceral Leishmaniasis
    Wasan, Kishor M.
    Wasan, Ellen K.
    Gershkovich, Pavel
    Zhu, Xiaohua
    Tidwell, Richard R.
    Werbovetz, Karl A.
    Clement, John G.
    Thornton, Sheila J.
    JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (03): : 357 - 360
  • [45] New lipid formulation of amphotericin B: spectral and microscopic analysis
    Larabi, M
    Gulik, A
    Dedieu, JP
    Legrand, P
    Barratt, G
    Cheron, M
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2004, 1664 (02): : 172 - 181
  • [46] Study of the toxicity of a new lipid complex formulation of amphotericin B
    Larabi, M
    Pages, N
    Pons, F
    Appel, M
    Gulik, A
    Schlatter, J
    Bouvet, S
    Barratt, G
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (01) : 81 - 88
  • [47] Effect of amphotericin B lipid formulation on immune response in aspergillosis
    Saxena, S
    Bhatnagar, PK
    Ghosh, PC
    Sarma, PU
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 188 (01) : 19 - 30
  • [48] Amphotericin B: Is a lipid-formulation gold standard feasible?
    Spellberg, B
    Witt, MD
    Beck, CK
    CLINICAL INFECTIOUS DISEASES, 2004, 38 (02) : 304 - 305
  • [49] Amphotericin B-loaded deformable lipid vesicles for topical treatment of cutaneous leishmaniasis skin lesions
    Manuela Carvalheiro
    Jennifer Vieira
    Catarina Faria-Silva
    Joana Marto
    Sandra Simões
    Drug Delivery and Translational Research, 2021, 11 : 717 - 728
  • [50] Amphotericin B-loaded deformable lipid vesicles for topical treatment of cutaneous leishmaniasis skin lesions
    Carvalheiro, Manuela
    Vieira, Jennifer
    Faria-Silva, Catarina
    Marto, Joana
    Simoes, Sandra
    DRUG DELIVERY AND TRANSLATIONAL RESEARCH, 2021, 11 (02) : 717 - 728
12345